Currently in shortage
AstraZeneca global API shortage. Critical for breast cancer patients — oncologist guidance essential before any change.
Expected resolution: 31 July 2025
Alternatives:
- Generic tamoxifen 20 mg — multiple brands, limited availability
- Letrozole (Femara) — aromatase inhibitor, post-menopausal patients only
tamoxifen citrate
Nolvadex-D
20 mg · tablet · Oncology
PBS Pricing
| General patient co-payment | $14.60 |
| Concession co-payment | $7.70 |
| Full dispensed price | $14.60 |
PBS Information
- Item code
- ONC003
- Drug name
- tamoxifen citrate
- Brand name
- Nolvadex-D
- Manufacturer
- AstraZeneca
- Formulation
- tablet
- Strength
- 20 mg
- Max quantity
- 30 units
- Max repeats
- 5
- PBS listed
- Yes
- Therapeutic group
- Oncology
TGA Reference: TGA-MSI-2025-022 · Sponsor: AstraZeneca Pty Ltd
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.